microRNA-30b inhibits cell invasion and migration through targeting collagen triple helix repeat containing 1 in non-small cell lung cancer

Table 1 miR-30b and Cthrc1 mRNA expression levels were associated with clinicopathological features of NSCLC patients

Clinicopathological factor	n	miR-30b(2^−ΔΔCt)		Cthrc1 mRNA(2^−ΔΔCt)
Clinicopathological factor	n	Median ± SD	P	Media ± SD	P
Gender
Male	38	0.2847 ± 0.1138	0.720	2.2714 ± 0.3568	0.707
Female	24	0.2960 ± 0.1307		2.2371 ± 0.3359
Age (years)
≥60	35	0.3081 ± 0.1324	0.156	2.222 ± 0.3971	0.345
<60	27	0.2644 ± 0.0979		2.305 ± 0.2672
Histology
SCC	21	0.3033 ± 0.0992	0.508	2.2548 ± 0.2960	0.957
AC	41	0.2818 ± 0.1295		2.2599 ± 0.3732
Differentiation
Well	21	0.3455 ± 0.1533	0.007*	2.1035 ± 0.4324	0.011*
Moderate & Poor	41	0.2602 ± 0.0870		2.3374 ± 0.2656
TNM
I	25	0.3540 ± 0.1327	0.000*	2.1010 ± 0.3440	0.005*
II	23	0.2663 ± 0.0927		2.3126 ± 0.2796
III	14	0.2107 ± 0.0677		2.4494 ± 0.3470
Lymphnode metastasis
N0	47	0.3129 ± 0.1234	0.005*	2.1952 ± 0.3290	0.010*
N1–N3	15	0.2147 ± 0.0670		2.4555 ± 0.3352

ISSN: 1475-2867